公司新闻»更多

Immune Tech 抗体和蛋白产品最新应用统计

发布时间:2013-04-28 09:34 点击次数:

1. 哈佛大学医学院,微生物学和免疫生物学系
J. Virol., Jan 2012; 86: 1145 - 1157. Thomas S. Postler et al.
Antibody reacted with recombinant SIVmac239 proteins gp140 and gp120 (Immune Technology Corp., New York, NY)

 2. 哈佛大学医学院,新英格兰灵长类动物研究中心
J. Virol., Jan 2011; 85: 582 - 595. Elizabeth Stansell et al.
Cells and purified using the His tag were purchased from Immune Technology Corp., New York, NY: SIVmac239, SIVsmE660, HIV-2 Ben, HIV-2. For SIV and HIV proteins purchased from Immune Technology Corp.
 
3. 哈佛大学医学院,新英格兰灵长类动物研究中心
J. Virol., Sep 2010; 84: 8998 - 9009. Elizabeth Stansell et al.
HIV-1 JRCSF gp120, HIV-1 p1006_11.C3.1601 gp120, HIV-1 consensus B gp120, HIV-1 consensus A2 gp120, HIV-1 consensus C gp120, SIVcpzEK505 gp120, and SIVcpzMB66 gp120 produced from HEK293 cells were purchased from Immune Technology Corp., New York, NY. GNA ELISA. For the case of SIV and HIV proteins purchased from Immune Technology Corp.
 
4. 哈佛大学儿童医院,儿科系
Cell structure Volume 18, Issue 12, 8 December 2010, Pages 1632–1641. Michael M. Freeman et al.
gp120 derived from the isolate Du156.12 from Immune Technology Corp. (New York, NY). Gp120 core, soluble 2D and 4D human CD4 were expressed in insect cells.
 
5. 美国国立卫生研究院,NIAID疫苗研究中心
J. Virol., Aug 2012; 86: 7760 - 7770. Lukas Flatz et al.
The ELISA plate was coated with either SIVmac239 gp140 or HIV gp120B (Immune Technology, NY).
 
6.美国国立卫生研究院,约翰·霍普金斯大学,美国食品和药物管理局(FDA)
Vaccine Volume 28, Issue 44, 18 October 2010, Pages 7193–7201. Chia Chu et al.
Wisconsin/67/2005 X-161, Cat. No. IT-003-004WI, Immune Technology Corp.
 
7. 美国国立卫生研究院,NIAID疫苗研究中心
J. Virol., Jul 2008; 82: 6200 - 6208. Chih-Jen Wei et al.
rabbit polyclonal anti-HA antibody (Immune Technology, New York, NY).
 
8. FDA,美国食品和药物管理局病毒产品事业部
J. Virol. JVI.01596-12; 5 September 2012. Swati Verma et al.
The H5N1-rHA1 or mammalian cell derived glycosylated HA0 proteins 235 Page 12. 12 (Immune Technology Corp) were coupled to a GLC sensor chip with amine coupling in 236 the test flow cells.
 
9. FDA,美国食品和药物管理局病毒产品事业部
PLoS ONE February 2011,Volume 6,Issue 2,e17297. Hanxin Lu et al.
Purified mammalian cell derived H5N1 HA1 or the HA0 proteins obtained from Immune Technology Corp.
 
10. FDA,美国食品和药物管理局病毒产品事业部
PLoS ONE July 2010 | Volume 5 | Issue 7 | e11548. Surender Khurana et al.
A mammalian cell derived recombinant full length HA (HA0) (from Immune Technology Corp, NY) were tested for binding to fetuin coated on biosensor chips.
 
11. 德国Georg-Speyer-Haus生物医学研究所
J. Virol., Oct 2010; 84: 10131 - 10138. Xavier Dervillez et al.
Overnight with 100 ng strain 89.6 gp120 (Immune Technology) per well. After the plates were...experiments with the gp120 variants (Immune Technology), purified ectodomain of human CD4 (Immune Technology).
 
12. 华盛顿Fred Hutchinson癌症研究中心。
J. Virol., Sep 2012; 86: 9566 - 9582. Leslie Goo et al.
Purified recombinant subtype C (BL035.W6M.ENV.C1; Immune Technology) proteins were used as gp120.
 
13. 加利福尼亚州MedImmune公司
J. Virol., Jul 2010; 84: 6570 - 6577. Weijia Wang et al.
Rabbit anti-HA1 (H5N1) antiserum was obtained from Immune Technology Corp. (New York, NY). Generation of recombinant viruses...before incubation with rabbit anti-HA1 (H5N1) antiserum (Immune Technology Corp., New York, NY), followed by incubation with horseradish.
 
14. 杜克大学医学院人类疫苗研究所
J. Virol., Jul 2011; 85: 7029 - 7036. Guido Ferrari et al.
Recombinant gp120 HIV-1 protein from the WITO (gp120WITO) early-infection Env clone (GenBank accession number AY835451 ) (Immune Technology Corp, New York).
 
15. 芝加哥伊利诺伊大学
J. Biol. Chem., Jul 2011; 286: 23975 - 23981. Jessica Celigoy et al.
A series of monoclonal antibodies. gp120 from strain YU2 was obtained from the Immune Technology Corp. gp120 from strain 96ZM65 was obtained from the National Institutes of Health AIDS Research.
 
16. 纽约罗切斯特大学医学中心
J. Immunol., May 2011; 186: 5514 - 5521. F. Eun-Hyung Lee et al.
Purified H1:2009 California (3 mug/ml; Immune Technology, New York, NY).
 
17. 休斯敦贝勒医学院
J. Virol. 2011, 85(20):10639. Lisa Golebiewski et al.
Primary antibodies used were to NS1 (Immune Tech Corp.).
 
18. 斯坦福大学化学工程系
Biotechnology and Bioengineering, 16 AUG 2012. John P. Welsh et al.
Commercial HA consisted of amino acids 18–529 of the 2009 pandemic H1N1 strain (HA(ΔTM)(A/California/07/2009(H1N1))) followed by a His 6 purification tag at the C-terminus (Immune Technology Corp., New York, NY).
 
19. 美国VaxInnate 公司,默克公司
Vaccine,18 September 2012. Ge Liu et al.
HA0 AN, recombinant HA (amino acids 18–530) of A/Anhui/1/2005 expressed from mammalian cells (Immune technology Corp., New York, New York).
 
20. 密歇根州立大学
Biosensors and Bioelectronics, 15 December 2010, Pages 1346–1352. Tracy L. Kamikawa et al.
Hemagglutinin (HA) protein (VN04-2), A/Vietnam/1203/04 (H5N1) (ascites, Mouse), NR-2728. The following were purchased from Immune Technology Corp. (New York, NY): (1) 6xHis tagged H5 hemagglutinin (HA) protein from 293 cell.
 
21. 加州大学药学院
Vaccine, 23 July 2009, Pages 4672–4683. Douglas S. Watson et al.
Recombinant gp140 ELISAs were performed as follows: Ba-1 gp140 (Immune Technology Corp,New York, NY).
 
22. 威斯康辛大学
PLoS Pathog 2011,7(11). Jason T. Weinfurter et al.
Purified HA proteins expressed in 293 cells were purchased from Immune Technology Corp. (New York, NY) for use in ELISAs.
 
23. 纽约大学医学院
Virology Volume 427, Issue 2, 5 June 2012, Pages 198–207. Miroslaw K. Gorny et al.
Recombinant HIV-1 proteins. Nineteen recombinant gp120s were purchased from Immune Technology Corp.
 
24. 澳大利亚洛伊癌症研究中心
J. Biol. Chem., Dec 2010; 285: 40072 - 40080. Iman Azimi et al.
anti-gp120/160 rabbit polyclonal antibody (Immune Technology).
 
25. 意大利bologna大学
Glycoconjugate Journal  Volume 27, Number 5 (2010), 501-513. Anna Kabanova et al.
IT-001-0029p), and gp120 JRFL (aa34–518, GenBank No. U63632, catalog no. IT- 001-0024p) were purchased from Immune Technology Corp. (New York, US). Polymun and Immune Technology recombinant proteins are expressed in CHO and 293T cells.
 
26. 法国Biceˆtre医院内科和传染病系
AIDS: 15 May 2009 - Volume 23 - Issue 8 - p 897-906. Lambotte, Olivier et al.
CEM.NKR cells were used as targets, coated with recombinant gp120 representing the sequences of the MN, JRFL, and QH0692 isolates rgp120JRFL and rgp120QH0692 (Immune Technology Corp, New York, USA).
 
27. 瑞士Linköping大学
Karlhans Fru Che et al.
HIV-1BaL gp120 protein was purchased from Immune Technology Corp., New York, NY.
 
28. 加拿大Medicago 公司
Plant Biotechnology Journal, pages 930–940, December 2008. Marc-André D’Aoust et al.
Anti-H5 immunoblotting was performed by incubation with rabbit anti-H5 (A/Vietnam/1203/2004) antibodies (Immune Technology, New York, NY, USA; Cat# IT-003-005V).
 
29. 香港大学新发传染性疾病国家重点实验室
PNAS, Jun 2008; 105: 8091 - 8096. Bo-Jian Zheng et al.
Influenza A viral proteins NP from H5N1 strain A/Indonesia/5/2005, HA1 from H5N1 strain A/Vietnam/1203/2004 (Immune Technology).
 
30. 香港大学生化系
BMC Immunology 2012, 13:54. Songyue Zheng et al.
H5 antigen (H5N1,A/Vietnam/1203/2004, Immune Technology Corp.) in 100 μl of PBS containing 0.2% BSA.
 
31. 北京理工大学生科院,中科院武汉病毒所
Anal. Chem., 2012, 84 (19), pp 8364–8370. Jian Hao et al.
anti-H3 protein (vaccinia virus) mouse monoclonal antibody (mAb) from Immune Technology Corp (USA).